Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. Balance Sheet 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 340.1M | 490.9M | 750.0M | 937.6M | 1.13B | 908.3M |
| Cash & Equivalents | 60.2M | 105.6M | 145.6M | 123.6M | 293.8M | 140.4M |
| Liabilities | ||||||
| Total Liabilities | 91.8M | 108.0M | 95.1M | 104.3M | 197.6M | 189.8M |
| Long-Term Debt | — | — | — | — | — | — |
| Equity | ||||||
| Shareholders' Equity | 248.2M | 382.8M | 655.0M | 833.3M | 929.8M | -292.5M |
Lyell Immunopharma, Inc. Balance Sheet — FAQ
Lyell Immunopharma, Inc. (LYEL) balance sheet over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LYEL's balance sheet history?
The chart and table above show Lyell Immunopharma, Inc.'s balance sheet by year and by quarter, including the growth rate.